Byers Eye Institute
Palo Alto, California, 94303, United States
Location status: Recruiting
NCT Number: NCT06128720
The purpose of the study is to evaluate the neuroprotective efficacy of hyperbaric oxygen for the treatment in patients with optic neuropathy.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Palo Alto, California, 94303, United States
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participant will undergo 60 minutes of Hyperbaric oxygen at 1.5ATA while breathing 100% oxygen
Participant will undergo 60 minutes of Sham Hyperbaric Oxygen at atmospheric pressure while breathing room air.
Time frame: Baseline through 6 months
Humphrey visual field testing with standard MD output
Time frame: Baseline through 6 months
Humphrey visual field testing with standard VFI output
Time frame: Baseline through 6 months
OCT testing with standard GCC output
Time frame: Baseline through 6 months
OCT testing with standard RNFL output
Contact information is provided by the study sponsor or research team.
Stanford University
Other
A Randomized, Sham Controlled, Masked Phase II Study to Evaluate the Neuroprotective Effect of Hyperbaric Oxygen Therapy on Optic Neuropathy
Acronym: HBOT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03011541
Abnormalities, Multiple, Age-Related Macular Degeneration
Westport, Connecticut, United States
View Trial DetailsNCT03318549
Cranial Nerve Diseases, Eye Diseases
Miami, Florida, United States
View Trial DetailsNCT01166594
Cranial Nerve Diseases, Eye Diseases
Toronto, Ontario, Canada
View Trial DetailsNCT02612571
Cranial Nerve Diseases, Eye Diseases
Philadelphia, Pennsylvania, United States
View Trial Details